4 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Active not recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Ileitis: new trials by email Literature Review of Ileitis trials Research Report on Ileitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis Vedolizumab, Concomitant Antibiotic Therapy - Pouchitis | Phase 3 | Recruiting | Takeda | 30 | 2024-11-19 | 2026-08-03 |
| Stelara fOr ChRonic AntibioTic rEfractory pouchitiS Ustekinumab - Pouchitis | Phase 3 | Completed | Universitaire Ziekenhuizen KU Leuven | 20 | 2020-06-15 | 2024-12-11 |
| the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis fecal microbiota, Placebo - Pouchitis | Phase 3 | Active not recruiting | Nantes University Hospital | 42 | 2020-03-12 | 2026-02-17 |
| The Role of Secondary Bile Acids in Intestinal Inflammation ursodiol (ursodeoxycholic acid, UDCA) - Ulcerative Colitis, Pouchitis | Phase 2 / Phase 3 | Terminated | Stanford University | 2 | 2019-08-26 | 2026-03-11 |
| Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics Alicaforsen, Placebo - Pouchitis | Phase 3 | Completed | Atlantic Pharmaceuticals Ltd | 138 | 2015-12-03 | 2020-02-25 |
| Adalimumab in the Treatment of Chronic Pouchitis Adalimumab, Placebo - Ulcerative Colitis, Pouchitis | Phase 3 | Completed | Odense University Hospital | 13 | 2012-08-01 | 2016-01-28 |
| Clinical Approaches to Ileal Pouch Dysfunction Electronic Barostat - Pouchitis | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 64 | 2010-03-18 |
Pouchitis (7) · Colitis, Ulcerative (2)
Digestive System Diseases (7) · Enteritis (7) · Gastroenteritis (7) · Gastrointestinal Diseases (7) · Ileal Diseases (7) · Intestinal Diseases (7) · Colitis (2) · Colonic Diseases (2) · Inflammatory Bowel Diseases (2)
Adalimumab (1) · Fecal Microbiota Transplantation (1) · Ursodeoxycholic Acid (1) · Ustekinumab (1) · alicaforsen (1) · vedolizumab (1)
Atlantic Pharmaceuticals Ltd (1) · Nantes University Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Odense University Hospital (1) · Stanford University (1) · Takeda (1) · Universitaire Ziekenhuizen KU Leuven (1)
Belgium (3) · United States (3) · France (2) · Israel (2) · Italy (2) · Canada (1) · Croatia (1) · Czechia (1) · Denmark (1) · Greece (1) · Ireland (1) · Netherlands (1) · Poland (1) · Spain (1) · Switzerland (1)
Bo Shen, M.D. (1) · Chris Dunk (1) · Jens Kjeldsen, Phd (1) · Marc Ferrante, MD, PhD (1) · Sidhartha Sinha, MD (1)
2023 (1), R03DK067275 (1)